Tech Company Financing Transactions
BioPharmX Funding Round
BioPharmX closed a $1.8 million funding round on 3/19/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
3/19/2015
Transaction Type
Debt
Amount
$1,750,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
115 Nicholson Ln.
San Jose, CA 95134
USA
San Jose, CA 95134
USA
Phone
Website
Email Address
Overview
BioPharmX, Inc. provides innovative drug-delivery products through its patented platform technologies for pharmaceutical and OTC applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Tierney
Chief Financial Officer
Joyce Goto
Chief Medical Officer
Scott Herron
Chief Operating Officer
Steven Bosacki
Browse more venture capital transactions:
Prev: 3/19/2015: MHB Labs venture capital transaction
Next: 3/19/2015: Clinical Ink venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs